Drug Shortage Report for ACH-PREGABALIN
Report ID | 161319 |
Drug Identification Number | 02449854 |
Brand name | ACH-PREGABALIN |
Common or Proper name | PREGABALIN |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 75MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-05-26 |
Estimated end date | Unknown |
Actual end date | 2022-08-27 |
Shortage status | Resolved |
Updated date | 2022-08-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-08-28 | English | Compare |
v5 | 2022-08-27 | French | Compare |
v4 | 2022-08-27 | English | Compare |
v3 | 2022-05-27 | English | Compare |
v2 | 2022-05-26 | French | Compare |
v1 | 2022-05-26 | English | Compare |
Showing 1 to 6 of 6